The Zecuity skin patch has been approved by the U.S. Food and Health Administration for use by adults who suffer from migraines with an aura or without
January 20, 2013 – The Zecuity skin patch has been approved by the U.S. Food and Health Administration for use by adults who suffer from migraines with an aura or without. The single-use only battery powered skin patch offers relief of nausea caused by migraines, as well as the migraine headache itself. Over 16 million adults in the U.S. suffer migraines.
Eight million of those also have nausea that is migraine related and usually avoid use of any oral medications. Along with the severe pain from the migraine, patients with have other significant symptoms, which can commonly include nausea said the patch’s manufacturer NuPathe Inc.
The patch can be applied to the area of the upper thigh or arm during the migraine and then activated by pushing a button Medicine is delivered via the patch through the wearer’s skin bypassing the patient’s stomach. Over a four-hour period, 6.5 milligrams of medication are delivered.
Studies of over 800 patients with migraines who used over 10,000 patches showed the patch effectively and safely relieved pain from migraines, nausea related to migraines and light and sound sensitivity within the first two hours of use.
The tests showed that after two hours of use 18% of the patients with the patch no longer had a headache, compared to just 9% of those who used a placebo. After two hours of use, 53% of those wearing patches, had some form of relief to their headache, compared to 29% who had just placebos. In addition, after just two hours, 84% using the patch did not have nausea, compared with 63% of those who received just a placebo.
Common side effects with the medication occurred in over 5% of the patients. The side effects included tingling at the patch site, warmth, itching and some discomfort. People with high blood pressure that is uncontrollable or with heart disease should not take the drug.